Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don B Sanders

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 12, 2025
Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomesOliver J McElvaney, Sonya L Heltshe, Don B Sanders, et al.
Annals of the American Thoracic Society|June 16, 2023
Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation TreatmentJonathan D Cogen, Don B Sanders, James E Slaven, et al.
International Journal of Molecular Sciences|June 13, 2025
Elexacaftor/Tezacaftor/Ivacaftor Supports Treatment for CF with ΔI1023-V1024-CFTRYunjie Huang, Jorge Moises Gonzales Cordova, Sarah Penrod, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 5, 2023
Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosisOliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2022
Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosisLucy Perrem, Sanja Stanojevic, Michelle Shaw, et al.
Annals of the American Thoracic Society|December 14, 2023
Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic FibrosisOliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, et al.
JAMA Pediatrics|August 1, 2022
Real-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary OutcomesMargaret Rosenfeld, Josh Ostrenga, Elizabeth A Cromwell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 17, 2023
Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosisBenjamin T Kopp, Sydney E Ross, Dinesh Bojja, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2025
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbationsRanjani Somayaji, Jonathan D Cogen, Donald VanDevanter, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 12, 2025
Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomesOliver J McElvaney, Sonya L Heltshe, Don B Sanders, et al.
Annals of the American Thoracic Society|June 16, 2023
Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation TreatmentJonathan D Cogen, Don B Sanders, James E Slaven, et al.
International Journal of Molecular Sciences|June 13, 2025
Elexacaftor/Tezacaftor/Ivacaftor Supports Treatment for CF with ΔI1023-V1024-CFTRYunjie Huang, Jorge Moises Gonzales Cordova, Sarah Penrod, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 5, 2023
Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosisOliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2022
Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosisLucy Perrem, Sanja Stanojevic, Michelle Shaw, et al.
Annals of the American Thoracic Society|December 14, 2023
Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic FibrosisOliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, et al.
JAMA Pediatrics|August 1, 2022
Real-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary OutcomesMargaret Rosenfeld, Josh Ostrenga, Elizabeth A Cromwell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 17, 2023
Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosisBenjamin T Kopp, Sydney E Ross, Dinesh Bojja, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2025
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbationsRanjani Somayaji, Jonathan D Cogen, Donald VanDevanter, et al.
Pageof 8